Valsts: Eiropas Savienība
Valoda: angļu
Klimata pārmaiņas: EMA (European Medicines Agency)
ivabradine hydrochloride
Les Laboratoires Servier
C01EB17
ivabradine
CARDIAC THERAPY
Angina Pectoris; Heart Failure
Symptomatic treatment of chronic stable angina pectorisIvabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. Ivabradine is indicated:in adults unable to tolerate or with a contraindication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.Treatment of chronic heart failureIvabradine is indicated in chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.
Revision: 26
Authorised
2005-10-25
28 B. PACKAGE LEAFLET 29 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CORLENTOR 5 MG FILM-COATED TABLETS CORLENTOR 7.5 MG FILM-COATED TABLETS ivabradine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Corlentor is and what it is used for 2. What you need to know before you take Corlentor 3. How to take Corlentor 4. Possible side effects 5 How to store Corlentor 6. Contents of the pack and other information 1. WHAT CORLENTOR IS AND WHAT IT IS USED FOR Corlentor (ivabradine) is a heart medicine used to treat: - Symptomatic stable angina pectoris (which causes chest pain) in adult patients whose heart rate is over or equal to 70 beats per minute. It is used in adult patients who do not tolerate or cannot take heart medicines called beta-blockers. It is also used in combination with beta-blockers in adult patients whose condition is not fully controlled with a beta-blocker. - Chronic heart failure in adult patients whose heart rate is over or equal to 75 beats per minute. It is used in combination with standard therapy, including beta-blocker therapy or when beta- blockers are contraindicated or not tolerated. About stable angina pectoris (usually referred to as “angina”): Stable angina is a heart disease which happens when the heart does not receive enough oxygen. The most common symptom of angina is chest pain or discomfort. About chronic heart failure : Chronic heart failure is a heart disease which happens when your heart cannot pump enough blood to the rest of your body. The most common s Izlasiet visu dokumentu
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Corlentor 5 mg film-coated tablets Corlentor 7.5 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Corlentor 5 mg film-coated tablets Each film-coated tablet contains 5 mg ivabradine (as hydrochloride). _Excipient with known effect:_ Each film-coated tablet contains 63.91 mg lactose monohydrate. Corlentor 7.5 mg film-coated tablets Each film-coated tablet contains 7.5 mg ivabradine (as hydrochloride). _Excipient with known effect:_ Each film-coated tablet contains 61.215 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Corlentor 5 mg film-coated tablets Salmon-coloured, oblong, film-coated tablet scored on both sides, engraved with “5” on one face and on the other face. The tablet can be divided into equal doses. Corlentor 7.5 mg film-coated tablets Salmon-coloured, triangular, film-coated tablet engraved with “7.5” on one face and on the other face. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of chronic stable angina pectoris Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. Ivabradine is indicated : - in adults unable to tolerate or with a contraindication to the use of beta-blockers - or in combination with beta-blockers in patients inadequately controlled with an optimal beta- blocker dose. Treatment of chronic heart failure 3 Ivabradine is indicated in chronic heart failure NYHA II to IV class with systolic dysfunction, in adult patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Symptomatic treatment of chronic stable angina pectoris _ It is recommended that the decision to ini Izlasiet visu dokumentu